Clinical Trial Update: Niraparib/TTFields in GBM [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating niraparib in combination with TTFields for glioblastoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Niraparib (Niraparib)
• OPTUNE

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING